SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES
๐ฎ๐ทIran
- Country
- ๐ฎ๐ทIran
- Ownership
- Private
- Established
- 1961-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sbmu.ac.ir/
The Role of Amniotic Membrane Transplantation in Ocular Chemical Burns
- First Posted Date
- 2006-09-01
- Last Posted Date
- 2008-09-25
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 90
- Registration Number
- NCT00370812
- Locations
- ๐ฎ๐ท
Labbafinejad Medical Center, Tehran, Iran, Islamic Republic of
The Effect of Hydrodynamic Parameters on Corneal Endothelial Cell Loss After Phacoemulsification
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-09-01
- Last Posted Date
- 2009-12-25
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT00370955
- Locations
- ๐ฎ๐ท
Alireza Baradaran Raffiee, Tehran, Iran, Islamic Republic of
The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of PVR
Phase 3
- Conditions
- First Posted Date
- 2006-09-01
- Last Posted Date
- 2007-07-12
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Registration Number
- NCT00371020
- Locations
- ๐ฎ๐ท
Hamid Ahmadieh, MD, Tehran, Iran, Islamic Republic of
To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema
Phase 1
- Conditions
- Interventions
- First Posted Date
- 2006-09-01
- Last Posted Date
- 2008-07-30
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT00371111
- Locations
- ๐ฎ๐ท
Masoud Soheilian , MD, Tehran, Iran, Islamic Republic of
Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
- First Posted Date
- 2006-09-01
- Last Posted Date
- 2008-07-11
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 31
- Registration Number
- NCT00370786
- Locations
- ๐ฎ๐ท
Hamid Ahmadieh, MD, Tehran, Iran, Islamic Republic of
Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
- First Posted Date
- 2006-09-01
- Last Posted Date
- 2008-06-26
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Registration Number
- NCT00370721
- Locations
- ๐ฎ๐ท
Hamid Ahmadieh, MD, Tehran, Iran, Islamic Republic of
Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)
Phase 3
- Conditions
- Interventions
- First Posted Date
- 2006-09-01
- Last Posted Date
- 2008-06-26
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Registration Number
- NCT00370760
- Locations
- ๐ฎ๐ท
Hamid Ahmadieh, MD, Tehran, Iran, Islamic Republic of
Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial
Phase 3
- Conditions
- First Posted Date
- 2006-08-31
- Last Posted Date
- 2007-03-13
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Registration Number
- NCT00370422
- Locations
- ๐ฎ๐ท
Hamid Ahmadieh, MD, Tehran, Iran, Islamic Republic of
Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD
Phase 3
- Conditions
- First Posted Date
- 2006-08-31
- Last Posted Date
- 2006-11-14
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Registration Number
- NCT00370539
- Locations
- ๐ฎ๐ท
Hamid Ahmadieh, MD, Tehran, Iran, Islamic Republic of
Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
Phase 3
- Conditions
- First Posted Date
- 2006-08-31
- Last Posted Date
- 2006-10-09
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Registration Number
- NCT00370201
- Locations
- ๐ฎ๐ท
Hamid Ahmadieh,MD, Tehran, Iran, Islamic Republic of
ยฉ Copyright 2024. All Rights Reserved by MedPath